Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
Background In this phase I/II trial, we evaluated the safety and effectiveness of pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from metastatic non-small cell lung cancer (mNSCLC).Methods Patients with lung or liver lesions amenable to RT plus at least one a...
Saved in:
| Main Authors: | Chad Tang, Patricia de Groot, James Welsh, Hari Menon, Dawei Chen, Vivek Verma, Mehmet Altan, Kenneth Hess, John V Heymach, Quynh-Nhu Nguyen, Rejani Varghese, Nathan I Comeaux, George Simon, Ferdinandos Skoulidis, Joe Y Chang, Vasiliki Papdimitrakopoulou, Steven H Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/2/e001001.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies
by: Wei Li, et al.
Published: (2024-10-01) -
Cytokine Release Syndrome Induced by Pembrolizumab for Metastatic Anal Melanoma
by: Erica Martel, et al.
Published: (2025-01-01) -
Pembrolizumab: The nut cracker
by: Gangothri Selvarajan
Published: (2020-01-01) -
Immune-induced thrombocytopenia by pembrolizumab: case report and review of literature
by: Nathan El-Ghazzi, et al.
Published: (2025-12-01) -
Utility of pembrolizumab for metastatic castrate resistant prostate cancer with MMR deficiency
by: Brian F. Dinerman, et al.
Published: (2024-11-01)